Advertisement BIT Analytical, DRG Diagnostics to unveil new Hybrid analyzer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BIT Analytical, DRG Diagnostics to unveil new Hybrid analyzer

BIT Analytical Instruments has collaborated with DRG Diagnostics to introduce a new fully-automated and integrated random-access DRG:Hybrid XL analyzer.

The analyzer is designed for the simultaneous measurement of immunoassays and clinical chemistry parameters including turbidimetric tests in one work routine.

Apart from usage of the Hybrid analyzer in small and medium-sized labs, it is suitable for high-workload laboratories performing special routine and niche parameters automatically.

The analyzer is flexible enough to measure 40 different tests from one sample or just one or two tests from 20 samples.

BIT will feature the new DRG:Hybrid XL analyzer at the 2012 annual meeting of the American Association of Clinical Chemistry in Los Angeles, CA, US, being held between 15-19 July 2012.